Quality-of-Life and Psychosocial Aspects in Patients with Ocular Toxoplasmosis: A Clinical Study in a Tertiary Care Hospital in Brazil

References

• Qian Y, Glaser T, Esterberg E, Acharya NR. Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol. 2012;153:2. doi:10.1016/j.ajo.2011.09.014.
   Web of Science ®Google Scholar
• Fernandez DG, Nascimento H, Nascimento C, Muccioli C, Belfort JR. Uveitis in São Paulo, Brazil: 1053 New Patients in 15 Months. Ocul Immunol Inflamm. 2016;00:1–6.
   Google Scholar
• Silva LM, Muccioli C, Oliveira F, et al. Visual impairment from uveitis in a reference hospital of Southeast Brazil: a retrospective review over a twenty years period. Arq Bras Oftalmol. 2013;76:366–369.
   PubMed Web of Science ®Google Scholar
• Silva LM, Arantes TE, Casaroli-Marano R, Vaz T, Jr R B, Muccioli C. Quality of life and psychological aspects in patients with visual impairment secondary to uveitis: A clinical study in a tertiary care hospital in Brazil. Ocul Immunol Inflamm. 2017;00(00):1–9. doi:10.1080/09273948.2017.1370551.
   Google Scholar
• Araújo Filho A, Salomão SR, Berezovsky A, et al. Prevalence of visual impairment, blindness, ocular disorders and cataract surgery outcomes in low-income elderly from a metropolitan region of São Paulo – brazil. Arq Bras Oftalmol. 2008;71(2):246–253. doi:10.1590/S0004-27492008000200021.
   PubMed Web of Science ®Google Scholar
• WHO. Visual impairment and blindness. http://www.who.int/mediacentre/factsheets/fs282/en/.AccessedAugust2014.
   Google Scholar
• Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology. 2007;114(2):238–245. doi:10.1016/j.ophtha.2006.10.027.
   PubMed Web of Science ®Google Scholar
• Hoeksema L, Los LI. Vision-related quality of life in herpetic anterior uveitis patients. In: Ploss One. 2014.9(1): e85224. http://www.plosone.org
   Google Scholar
• Holland GN. Lx edward jackson memorial lecture ocular toxoplasmosis: A global reassessment. Part I: epidemiology and Course of Disease. Am J Ophthalmol. 2003;136:973–988.
   PubMed Web of Science ®Google Scholar
• Foster CS, Vitale AT. Diagnosis and treatment of uveitis. In: Toxoplasmosis. 2nd. Vol. 35. New Delhi: Jaypee Brothers; 2013:543–564.
   Google Scholar
• Kovačević-Pavićević D, Radosavljević A, Ilić A, Kovačević I, Djurković-Djaković O. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia. Eye (Lond). 2012;26(5):723–728. doi:10.1038/eye.2012.20.
   PubMed Web of Science ®Google Scholar
• Review: FJ. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma–human model in studying the manipulation hypothesis. J Exp Biol. 2013;216:127–133. doi:10.1242/jeb.073635.
   PubMed Web of Science ®Google Scholar
• Adán A, Giralt J, Alvarez G, et al. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009;19:1039–1043.
   PubMed Web of Science ®Google Scholar
• Papadopoulou DN, Petropoulos IK, Mangioris G, Pharmakakis NM, Pournaras CJ. Pars plana vitrectomy in the treatment of severe complicated toxoplasmic retinochoroiditis. Eur J Ophthalmol. 2011;21:83–88.
   PubMed Web of Science ®Google Scholar
• https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
   Google Scholar
• Dandona L, Dandona R. Revision of visual impairment definitions in the international statistical classification of diseases. In: BMC Medicine, Vol. 4. Jan; 2006:7.
   Google Scholar
• As Z, Rp S. The hospital and anxiety and depression scale. Acta Psychiatr Scand. 1983;7:361–370.
   Google Scholar
• Globe DR, Levin S, Chang TS, Mackenzie PJ, Azen S. Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology. 2002;109(10):1793–1798. doi:10.1016/S0161-6420(02)01124-7.
   PubMed Web of Science ®Google Scholar
• Andrade TL, Camelier AA, Rosa FW, et al. Applicability of the 12-item short health survey in patients with progressive systemic sclerosis. J Bras Pneumol. 2007;33(4):414–422. doi:10.1590/S1806-37132007000400010.
   PubMedGoogle Scholar
• Cruz LN, Fleck MP, Oliveira MR, et al. Health-related quality of life in Brazil: normative data from the SF-36 in a general population sample in the south of country. Cien Saude Colet. 2013;18(7):1911–1921. doi:10.1590/S1413-81232013000700006.
   PubMed Web of Science ®Google Scholar
• Younsi M. Health-related quality-of-life measures: evidence from tunisian population using the SF-12 health survey. Value Health Reg Issues. 2015;7:54–66. doi:10.1016/j.vhri.2015.07.004.
   PubMedGoogle Scholar
• Jenkinson C, Chandola T, Coulter A, Bruster S. An assessment of the SF- 12 summary scores across ethnic groups. J Pub Health Med. 2001;23:187–194. doi:10.1093/pubmed/23.3.187.
   PubMedGoogle Scholar
• Jenkinson C, LayteR, Jenkinson D, et al. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J Pub Health Med. 1997;19:179–186. doi:10.1093/oxfordjournals.pubmed.a024606.
   PubMedGoogle Scholar
• Ware JE, Gandek B, Keller SD. The IQOLA Project Group. Evaluating instruments used cross-nationally: methods from the IQOLA Project. In: Spilker B, ed.. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd. New York: Raven Press; 1996
   Google Scholar
• Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminar test of reliability and validity. Med Care. 1996;34:220–233. doi:10.1097/00005650-199603000-00003.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr., Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual of Users of Version 1. Second. Lincoln, RI: Quality Metric Incorporated; 2001.
   Google Scholar
• Ware JE, Kosinski M, Turner-Bowker DM, et al. How to Score Version 2 of the SF-12® Health Survey (With a Supplement Documenting Version1. Lincoln RI: Qulaity Metric Incorporation; 2002.
   Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119:1050–1058. doi:10.1001/archopht.119.7.1050.
   PubMed Web of Science ®Google Scholar
• Hirneia C, Schmid-Tannwald C, Kernt M, Kampik A, Newbauer AS. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol. 2010;248:85–92. doi:10.1007/s00417-009-1275-3.
   PubMed Web of Science ®Google Scholar
• Milne A, Johnson JA, Tennant M, Rudnisky C, Dryden DM. Measuring health-related quality of life for patients with diabetic retinopathy. Technol Assess Rep. 2012.
   Google Scholar
• Suner IH, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation Studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009;50:3629–3655. doi:10.1167/iovs.08-3225.
   PubMed Web of Science ®Google Scholar
• Simão LM, Lana-Peixoto MA, Araujo CR, Moreira MA, Teixeira AL. The Brazilian version of the 25-item national eye institute visual function questionnarie: translation, realiability and validity. Arq Bras Oftalmol. 2008;71(4):540–546. doi:10.1590/S0004-27492008000400014.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmolol. 2001;119:841–849. doi:10.1001/archopht.119.6.841.
   PubMed Web of Science ®Google Scholar
• .http://bvsms.saude.gov.br/bvs/publicacoes/saude_brasil_2010.pdf
   Google Scholar
• Mt A, Belfort R Jr, Oréfice F. Toxoplasmose. In Roca ed. Uveítes, Vol. 21. Fernando Oréfice e Rubens Belfort Jr; 1987:212–230.
   Google Scholar
• Frick KD, Drye LT, Kempen JH, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012;53:1169–1176. doi:10.1167/iovs.11-8259.
   PubMed Web of Science ®Google Scholar
• Mayer H, Kraus-Mackiw E, Arocker-Mettinger E, et al. Psychosomatic aspects of uveitis in the context of working life. In Nussenblatt RB, Whitcup SM, Caspi RR, et al. eds. Advances in Ocular Immunology. Amsterdam: Elsevier Science; 1994:349–352.
   Google Scholar
• Iwahashi-Shima C, Sato T, Bando H, Ikeda T, Emi K. Anatomic and functional outcomes of 25-gauge vitrectomy for repair of eyes with rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy. Clin Ophthalmol. 2013;7:2043–2049. doi:10.2147/OPTH.S52260.
   PubMedGoogle Scholar
• Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 2000;107:36–40.
   PubMed Web of Science ®Google Scholar
• Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5:56. doi:10.3389/fnagi.2013.00056.
   PubMed Web of Science ®Google Scholar
• van der Aa HP, Xie J, Rees G, et al. Validated prediction model of depression in visually impaired older adults. Ophthalmology. 2016;123:1164–1166. doi:10.1016/j.ophtha.2015.11.028.
   PubMed Web of Science ®Google Scholar
• Flegr J, Preiss M, Klose J, Havlícek J, Vitáková M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–268.
   PubMed Web of Science ®Google Scholar
• Flegr J. Effects of toxoplasma on human behavior. Schizophr bull. 2007;33(3):757–760.
   Google Scholar
• Hui MM, Wakefield D, Patel I, et al. Visual functioning and health related quality-of-life are compromised in patients with uveitis. Ocul Immunol Inflamm. 2016;22:1–6.
   Google Scholar
• Hirneiß C, Schmid-Tannwald C, Kernt M, Kampik A, Neubauer AS. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol. 2010;248:85–92. doi:10.1007/s00417-009-1275-3.
   PubMed Web of Science ®Google Scholar
• Melo PRAAP, Roma AC, Moraes JHV. Analysis of life quality of infectious and onn-infectious patients with uveitis using the NEI-VFQ-25 questionnaire. Arq Bras Oftalmol. 2008;71:847–854.
   PubMed Web of Science ®Google Scholar
• De La Torre A, Lopez GG, Gutierrez JMM, Arango VM, Marin JEG. Quality of life assessment in ocular toxoplasmosis in a colombian population. Ocul Immunol Inflamm. 2011;19(4):262–266. doi:10.3109/09273948.2011.582220.
   PubMed Web of Science ®Google Scholar
• Peyron F, Garqeg JG, Wallon M, Descloux E, Rolland M, Barth J. Long-term Impacto f treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J. 2011;30(7):597–600. doi:10.1097/INF.0b013e31820bb5f3.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277. doi:10.1371/journal.pntd.0000326.
   PubMed Web of Science ®Google Scholar
• O’Donnell S, Cheung R, The BK. survey on living with chronic diseases in Canada on mood and anxiety disorders: a methodological overview. Health Promot Chronic Dis Prev Can. 2014;2016:275–288.
   Google Scholar
• Heun R, Papassotiropoulos A, Ptok U. Subthreshold depressive and anxiety disorders in the elderly. Eur Psychiatry. 2000;15:173–182. doi:10.1016/S0924-9338(00)00228-5.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Hughes EH, Frost NA, Ainsworth JR, Page AB, McLean WHI. Quality of life and visual function in patients with intermediate uveitis. Br J Ophthalmol. 2005;89:1161–1165. doi:10.1136/bjo.2004.059121.
   PubMed Web of Science ®Google Scholar
• Hoeksema L, Los LI. Vision-related quality of life in herpetic anterior uveitis patients. PLoS ONE. 2014;9(1):e85224. doi:10.1371/journal.pone.0085224.
   PubMed Web of Science ®Google Scholar
• Dev MK, Paudel N, Joshi ND, Shah DN, Subba S. Psycho-social impact of visual impairment on health-related quality of life among nursing home residents. BMC Health Serv Res. 2014;14:345. doi:10.1186/1472-6963-14-345.
   PubMed Web of Science ®Google Scholar